The nice people at Medscape sent some information on myelofibrosis today. All rather more clinical than technical, but that can be said of most of the stuff I read these days…
'Impressive' Results After Change of HSCT Conditioning Regimen in Myelofibrosis Patients
JAK1/2 Inhibitors Linked to Lymphoma Risk in Myelofibrosis
No comments:
Post a Comment